We are live on ! Find out more
ROIVW

Roivant Sciences Ltd. Warrant
ROIVW

Delisted

ROIVW was delisted on the 1st of September, 2023.

Back to rankings

31 hedge funds and large institutions have $19.8M invested in Roivant Sciences Ltd. Warrant in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

14% less funds holding

Funds holding: 36 → 31 (-5)

22% less capital invested

Capital invested by funds: $25.5M → $19.8M (-$5.65M)

63% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 8

Holders
31
Holders Change
-5
Holders Change %
-13.89%
% of All Funds
0.52%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
6
Reduced
4
Closed
8
Calls
$3.65M
Puts
–
Net Calls
+$3.65M
Net Calls Change
-$945K

Top Buyers

Rank Fund Capital Flow
1
LP
LMR Partners
United Kingdom
+$236K
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$127K
3
MF
Magnetar Financial
Illinois
+$105K
4
Walleye Capital
Walleye Capital
New York
+$34.8K
5
OMC
Old Mission Capital
Illinois
+$9.58K

Top Sellers

Rank Fund Capital Flow
1
BCM
Beryl Capital Management
California
-$471K
2
WP
Woodline Partners
California
-$316K
3
SAMU
SONA Asset Management (US)
New York
-$193K
4
SCM
Shaolin Capital Management
Florida
-$44K
5
TCA
Taconic Capital Advisors
New York
-$41K
Name Holding Trade Value Shares
Change 		Change in
Stake
LP
1
LMR Partners
United Kingdom
$14M +$236K +450,123 +15%
HCM
2
Highbridge Capital Management
New York
$1.18M – – –
CC
3
Centiva Capital
New York
$1.09M -$1.52K -2,900 -0.2%
AC
4
Aristeia Capital
Connecticut
$789K -$23.9K -45,647 -3%
DM
5
Deerfield Management
New York
$600K – – –
SAM
6
Serengeti Asset Management
New York
$422K – – –
CC
7
Clearline Capital
New York
$191K – – –
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
$146K +$127K +242,918 New
KC
9
Kepos Capital
New York
$143K – – –
Jane Street
10
Jane Street
New York
$122K +$308 +588 +0.3%
MCM
11
Moore Capital Management
New York
$120K – – –
PVI
12
Pura Vida Investments
New York
$120K – – –
TCM
13
Tenor Capital Management
New York
$120K – – –
BFM
14
Boothbay Fund Management
New York
$106K +$1.35K +2,581 +11%
ACM
15
Atalaya Capital Management
New York
$90K – – –
Balyasny Asset Management
16
Balyasny Asset Management
Illinois
$90K – – –
CM
17
Caption Management
Oklahoma
$76K – – –
TSC
18
Two Seas Capital
New York
$67K – – –
CP
19
Covalent Partners
Massachusetts
$60K – – –
Walleye Capital
20
Walleye Capital
New York
$50K +$34.8K +66,565 +400%
ACA
21
Arena Capital Advisors
California
$36K – – –
DC
22
Diametric Capital
Massachusetts
$36K +$76 +145 +0.2%
ECU
23
Eisler Capital (UK)
United Kingdom
$27K – – –
CCA
24
Castle Creek Arbitrage
Colorado
$24K – – –
PCM
25
Prelude Capital Management
New York
$19K -$896 -1,712 -5%
1
2

ROIVW Hedge Fund Activity: Q2 2022 in Review

31 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences Ltd. Warrant (ROIVW) for Q2 2022, worth a combined $19.8M — down 22% from $25.5M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ROIVW and 3 opened new positions — a net loss of 5 holders — while 4 trimmed existing stakes and 6 added.

The largest buyer was LMR Partners, adding an estimated $236K. The largest seller was Beryl Capital Management, exiting entirely with an estimated $471K sold.

  • 31 institutional investors held Roivant Sciences Ltd. Warrant (ROIVW) as of Q2 2022, down from 36 in Q1 2022.
  • Funds reported $19.8M of Roivant Sciences Ltd. Warrant stock for Q2 2022, down 22% quarter-over-quarter.
  • 3 funds opened new Roivant Sciences Ltd. Warrant positions in Q2 2022 and 8 closed out, a net change of -5 holders.
  • The largest Roivant Sciences Ltd. Warrant buyer in Q2 2022 was LMR Partners, an estimated $236K added.
  • The largest Roivant Sciences Ltd. Warrant seller in Q2 2022 was Beryl Capital Management, an estimated $471K sold.

Based on aggregated 13F filings for Q2 2022.